Biotechnology -

ESYA Labs Partners with Alamar Biosciences to Advance Biomarker Detection and Diagnostics for Neurological Diseases

ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a transformative partnership with Alamar Biosciences, a pioneer in ultra-sensitive immunoassay technologies. By merging their respective strengths, the collaboration aims to revolutionise the detection and quantification of biomarkers for neurological and inflammatory diseases, using Alamar’s NULISA™ platform and ARGO™ HT System. These advanced technologies will be made available through ESYA’s cutting-edge laboratory in Dallas, Texas. “We are thrilled to...

by Ankita Bhokre

Biotechnology

City microbes surviving on disinfectants, research reveals

After the recent pandemic, our use of disinfectants has increased, but are our efforts to create sterile urban environments backfiring? A new study published in the journal Microbiome has identified novel strains of microbes that have adapted to use the limited resources available in cities and shown that our everyday behaviour is changing the makeup of microorganisms in indoor environments. Specialized metabolic capacities of microbes in oligotrophic built environments. Tong et al. “Diverse and specialized metabolic capabilities...

by business wire

Biotechnology

PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics

At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow, which simplifies, speeds up and standardizes FFPE sample preparation for deep, unbiased tissue proteomics by subsequent protein digestion and nanoLC-MS/MS analysis. The novel BeatBox workflow eliminates the need for xylene-based deparaffinization and enables fast and robust processing of up to 96 samples in parallel for discovery research, as well as for reproducible larger cohort translational and preclinical research and validation. The BeatBox™ tissue...

by PRNewswire

Biotechnology Cloud

More than 100 Biopharmas Increase Impactful Engagement with Veeva CRM Events Management

Veeva Systems (NYSE: VEEV) today announced more than 100 life sciences companies are using Veeva CRM Events Management to plan and execute in-person, virtual, and hybrid events worldwide. Supporting more than one million medical and commercial events to date, Events Management is helping teams lead more impactful healthcare professional (HCP) and key opinion leader (KOL) education and peer-to-peer interactions across channels. How GSK, Jazz Pharmaceuticals, and Kyowa Kirin International are advancing tailored, adaptive events: “Our global events strategy is...